PTPLAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.454000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.252100E-02
Normal-vs-Stage2
2.580400E-01
Normal-vs-Stage3
8.426600E-01
Normal-vs-Stage4
8.668400E-02
Stage1-vs-Stage2
1.161790E-01
Stage1-vs-Stage3
2.806200E-02
Stage1-vs-Stage4
7.028600E-01
Stage2-vs-Stage3
2.891400E-01
Stage2-vs-Stage4
3.358800E-01
Stage3-vs-Stage4
1.043820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.489400E-01
Normal-vs-AfricanAmerican
1.427150E-01
Normal-vs-Asian
4.557800E-01
Caucasian-vs-AfricanAmerican
9.249400E-01
Caucasian-vs-Asian
6.886800E-01
AfricanAmerican-vs-Asian
7.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.697000E-01
Normal-vs-Female
2.332800E-01
Male-vs-Female
6.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.724970E-01
Normal-vs-Age(41-60Yrs)
1.416380E-01
Normal-vs-Age(61-80Yrs)
3.403000E-01
Normal-vs-Age(81-100Yrs)
1.937790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.111000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.070600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.777000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.498400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.060000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.196800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.132000E-01
Normal-vs-Daily Drinker
4.809000E-01
Normal-vs-Weekly Drinker
4.422200E-01
Normal-vs-Occasional Drinker
2.554200E-01
Normal-vs-Social Drinker
4.079800E-01
Non Drinker-vs-Daily Drinker
4.064000E-01
Non Drinker-vs-Weekly Drinker
6.690200E-01
Non Drinker-vs-Occasional Drinker
2.555000E-01
Non Drinker-vs-Social Drinker
5.949800E-01
Daily Drinker-vs-Weekly Drinker
7.848800E-01
Daily Drinker-vs-Occasional Drinker
1.005580E-01
Daily Drinker-vs-Social Drinker
8.305600E-01
Weekly Drinker-vs-Occasional Drinker
2.046000E-01
Weekly Drinker-vs-Social Drinker
9.452800E-01
Occasional Drinker-vs-Social Drinker
1.461560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.939200E-01
Normal-vs-Grade 2
2.729200E-01
Normal-vs-Grade 3
2.408200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.014600E-01
Grade 1-vs-Grade 3
3.503200E-01
Grade 1-vs-Grade 4
3.939200E-01
Grade 2-vs-Grade 3
8.814200E-01
Grade 2-vs-Grade 4
2.729200E-01
Grade 3-vs-Grade 4
2.408200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.434200E-01
Normal-vs-NonDiabetic
2.452200E-01
Diabetic-vs-NonDiabetic
8.015900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.058800E-01
Normal-vs-NoPancreatitis
2.735800E-01
Pancreatitis-vs-NoPancreatitis
9.509400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.300000E-01
Normal-vs-N1
2.470400E-01
N0-vs-N1
1.251610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.417900E-02
Normal-vs-TP53-NonMutant
2.131600E-01
TP53-Mutant-vs-TP53-NonMutant
6.961000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
